文献速递妇科

肥胖与I型子宫癌的关联是否过于简化

The association of obesity with type I uterine cancer-is this an oversimplification?
PubMed 文献 · Am J Obstet Gynecol · 2022-05-11

该研究利用美国2001至2017年国家癌症统计数据库与行为危险因素监测系统数据,分析子宫癌I型/II型发病率与肥胖趋势的关系。17年间778,891例患者被诊断为子宫癌,总体发病率年增0.82%(P<.005),I型子宫内膜癌发病率稳定(AAPC 0.40,P=.061),II型年增3.12%(P<.001),肥胖比例从19.5%升至27.5%(AAPC 1.5,P<.001)。作者认为传统I/II型分类与肥胖的关系可能过于简化。

要点

  • 17年间子宫癌总体发病率年增0.82%(P<.005),2017年达27.04/10万。
  • I型子宫内膜癌发病率稳定(AAPC 0.40,P=.061),II型年增3.12%(P<.001)。
  • 肥胖女性比例从19.5%升至27.5%(AAPC 1.5,P<.001)。

核心结论

  • 利用17年国家癌症登记数据,高风险II型子宫内膜癌发病率增加,而低风险I级子宫内膜癌发病率保持稳定;肥胖比例上升,传统I/II型分类与肥胖的关系可能过于简化。

研究设计与样本

  • 研究数据来自美国癌症统计数据库和行为危险因素监测系统调查,时间范围为2001至2017年。
  • 研究期间共778,891例患者被诊断为子宫癌,采用Joinpoint回归计算发病率、组织学类型、肥胖及平均年度百分比变化(AAPC)。
  • 子宫内膜组织学按传统I型(子宫内膜样1–3级)和II型(浆液性、透明细胞、癌肉瘤)分类。

主要发现

  • 子宫癌新发病例率每年增加0.82%(P<.005),2001年发病率为24.07/10万,2017年为27.04/10万。
  • I型子宫内膜癌发病率保持稳定(AAPC 0.40,P=.061),其中1级子宫内膜癌发病率稳定(AAPC −0.48,P=.125),2级和3级子宫内膜癌发病率下降(AAPC分别为−2.61和−2.63,P<.001)。
  • II型子宫内膜癌发病率每年增加3.12%(P<.001),自2001年以来增加63%;浆液性癌每年增加4.88%(P<.001),透明细胞癌和癌肉瘤也显著增加(AAPC分别为1.02和1.51,P<.05)。
  • 肥胖女性比例从19.5%上升至27.5%(AAPC 1.5,P<.001)。

局限性

  • 可能存在信息报告偏倚。
  • 缺乏中心病理学审查。
  • 多数据库间数据关联能力有限。
  • 发病率未根据子宫切除术患病率进行校正。
  • 这些趋势提示肥胖对II型子宫内膜癌发病率上升可能存在影响,应进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE:: Endometrial cancer (EC) is increasing in incidence and mortality rates, possibly due to the rising rates of obesity in the United States. The type I/II EC classification system was first proposed by Bokhman in 1983 following 20 years of personal observations among 366 women and established obesity as a classical risk factor for low-grade EC with a good prognosis. However, more recent pooled analyses suggest that the 2 types share many etiologic risk factors, including obesity. Given the increase in mortality as a consequence of high-risk EC, the relationship between obesity and uterine cancer, as proposed by Bohkman, may be oversimplified. This study aimed to analyze the trend of type I/II EC in the United States as it relates to obesity using national statistics. STUDY DESIGN:: Data were obtained from the United States Cancer Statistics database and the Behavioral Risk Factors Surveillance System survey from 2001 to 2017. The incidence of uterine cancer, histologic type, obesity, and average annual percentage change (AAPC) were calculated using Joinpoint regression. Endometrial histology was classified according to traditional type I (endometrioid grade 1–3) and type II (serous, clear cell, carcinosarcoma) categories. RESULTS:: Over this 17-year study period, 778,891 patients were diagnosed with uterine cancer. Overall, the rate of new uterine cancer cases increased by 0.82% annually (P<.005), leading to an incidence of 24.07 per 100,000 in 2001 as compared with 27.04 per 100,000 women in 2017. The incidence of type I EC remained stable (AAPC, 0.40; P=.061) with a stable incidence of grade I EC (AAPC, −0.48; P=.125) and a decreasing incidence of grade 2 and grade 3 EC (AAPC, −2.61 and −2.63, respectively; P<.001). Alternatively, the incidence of type II EC increased by 3.12% annually (P<.001), leading to an increase of 63% since 2001. Serous carcinoma increased by 4.88% annually (P<.001). Clear cell and carcinosarcoma also increased significantly (AAPC, 1.02 and 1.51, respectively; P<.05). For illustrative purposes, we calculated the percentage increase in the incidence of cancer types over the last 17 years in comparison with the year 2001 (Figure). Overall, the proportion of women with obesity also increased significantly from 19.5% to 27.5% during this period (AAPC, 1.5; P<.001). CONCLUSION:: Utilizing 17 years of data from a national cancer registry, we demonstrated that the incidence of high-risk type II EC has increased, whereas the incidence of low-risk grade I EC has remained stable. In another survey study, we showed the rising incidence of obesity. These findings suggest that the traditional type I/II approach to classifying EC may be oversimplified, particularly as it relates to obesity. Recent studies utilizing The Cancer Genome Atlas classification for EC demonstrated an association between a mean body mass index (BMI) of ≥30 and each of the 4 clusters except for DNA polymerase epsilon gene ultramutated tumors. Furthermore, up-regulation of several genes known to play a role in EC pathogenesis were associated with BMI, suggesting that obesity may create a unique, proinflammatory microenvironment that affects tumor biology at a molecular level. Limitations of the current study include possible information reporting bias, lack of central pathology review, and limited ability to correlate data between multiple databases. Incidence rates are also not corrected for hysterectomy prevalence. However, these trends suggest a potential impact of obesity on the rising rates of type II EC that should be explored further.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Eakin CM, Liao CI, Salani R, et al. The association of obesity with type I uterine cancer-is this an oversimplification? Am J Obstet Gynecol. 2022. PMID: 35562051. doi:10.1016/j.ajog.2022.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。